1.20
price down icon6.25%   -0.08
pre-market  Pre-market:  1.25   0.05   +4.17%
loading
Pacific Biosciences Of California Inc stock is traded at $1.20, with a volume of 10.74M. It is down -6.25% in the last 24 hours and down -18.92% over the past month. Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
See More
Previous Close:
$1.28
Open:
$1.3
24h Volume:
10.74M
Relative Volume:
1.00
Market Cap:
$328.64M
Revenue:
$188.87M
Net Income/Loss:
$-400.38M
P/E Ratio:
-0.80
EPS:
-1.5
Net Cash Flow:
$-260.90M
1W Performance:
-7.69%
1M Performance:
-18.92%
6M Performance:
-33.70%
1Y Performance:
-71.70%
1-Day Range:
Value
$1.18
$1.30
1-Week Range:
Value
$1.18
$1.47
52-Week Range:
Value
$1.16
$4.2292

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
Name
Pacific Biosciences Of California Inc
Name
Phone
650-521-8000
Name
Address
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
Employee
796
Name
Twitter
@pacbio
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
PACB's Discussions on Twitter

Compare PACB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
PACB
Pacific Biosciences Of California Inc
1.20 328.64M 188.87M -400.38M -260.90M -1.50
Medical Devices icon
ABT
Abbott Laboratories
129.89 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.37 140.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
363.66 138.77B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.33 118.39B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
67.95 39.95B 5.72B 4.17B 259.90M 6.97

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-11-24 Downgrade UBS Buy → Neutral
Jun-03-24 Resumed Jefferies Buy
Apr-22-24 Downgrade JP Morgan Overweight → Neutral
Apr-18-24 Downgrade Goldman Buy → Neutral
Dec-14-23 Initiated Guggenheim Neutral
Dec-14-23 Initiated Stephens Overweight
Dec-13-23 Initiated Wolfe Research Peer Perform
Nov-17-23 Upgrade UBS Neutral → Buy
Oct-31-23 Upgrade Cantor Fitzgerald Neutral → Overweight
Sep-28-23 Initiated Bernstein Outperform
Jul-05-23 Resumed JP Morgan Overweight
Jun-30-23 Initiated Goldman Buy
May-10-23 Initiated Barclays Equal Weight
Mar-31-23 Upgrade TD Cowen Market Perform → Outperform
Feb-02-23 Initiated UBS Neutral
Jan-20-23 Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-05-23 Initiated Scotiabank Sector Outperform
Jan-21-22 Resumed Cantor Fitzgerald Overweight
Jan-06-22 Resumed Piper Sandler Neutral
Oct-15-21 Resumed Cowen Market Perform
Sep-27-21 Initiated Canaccord Genuity Buy
Feb-11-21 Upgrade Piper Sandler Neutral → Overweight
Nov-03-20 Downgrade Piper Sandler Overweight → Neutral
Oct-02-20 Upgrade JP Morgan Neutral → Overweight
Sep-09-20 Initiated Morgan Stanley Equal-Weight
Jun-02-20 Resumed Cantor Fitzgerald Overweight
Mar-09-20 Resumed Cantor Fitzgerald Overweight
Oct-15-19 Upgrade Piper Jaffray Neutral → Overweight
Apr-02-19 Downgrade Stephens Overweight → Equal-Weight
Oct-19-18 Initiated Cowen Outperform
Nov-03-17 Downgrade First Analysis Sec Overweight → Equal-Weight
Sep-28-17 Downgrade CL King Buy → Neutral
Nov-03-16 Reiterated Cantor Fitzgerald Buy
Jun-27-16 Initiated CL King Buy
Apr-15-16 Initiated First Analysis Sec Overweight
Feb-04-16 Downgrade Piper Jaffray Overweight → Neutral
Jan-04-16 Reiterated Cantor Fitzgerald Buy
Oct-23-15 Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15 Initiated Cantor Fitzgerald Buy
Feb-04-15 Reiterated Maxim Group Buy
Sep-26-13 Reiterated Maxim Group Buy
Jan-14-13 Reiterated Maxim Group Buy
View All

Pacific Biosciences Of California Inc Stock (PACB) Latest News

pulisher
Mar 13, 2025

Pacific Biosciences secures extended lease with rent abatement - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Re - GuruFocus.com

Mar 13, 2025
pulisher
Mar 13, 2025

2024 SMRT Conserve grant winners - Pacific Biosciences

Mar 13, 2025
pulisher
Mar 07, 2025

Pacific Biosciences of California, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

Selected publications from February 2025 - Pacific Biosciences

Mar 06, 2025
pulisher
Mar 05, 2025

Pacific Biosciences COO Mark Van Oene sells $9,125 in company stock - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Pacific Biosciences CEO sells $17,583 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Pacific Biosciences CEO sells $17,583 in stock - Investing.com

Mar 05, 2025
pulisher
Feb 28, 2025

ARK Investment Management LLC Buys 2,637,961 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Rare Disease Month: Putting People First - Pacific Biosciences

Feb 27, 2025
pulisher
Feb 27, 2025

Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know - MSN

Feb 27, 2025
pulisher
Feb 26, 2025

Investor Network: Pacific Biosciences of California, Inc. to Host Earnings Call - ACCESS Newswire

Feb 26, 2025
pulisher
Feb 26, 2025

Chromosome-level genome assembly and improved annotation of onion genome ( Allium cepa L.) - Nature.com

Feb 26, 2025
pulisher
Feb 25, 2025

Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock - Seeking Alpha

Feb 25, 2025
pulisher
Feb 24, 2025

Pacific Biosciences of California's (PACB) "Neutral" Rating Reaffirmed at Piper Sandler - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $45,776.12 in Stock - MarketBeat

Feb 23, 2025
pulisher
Feb 22, 2025

PacBio cut to Neutral at Goldman Sachs after guidance cut - MSN

Feb 22, 2025
pulisher
Feb 22, 2025

Revenue Downgrade: Here's What Analysts Forecast For Pacific Biosciences of California, Inc. (NASDAQ:PACB) - Simply Wall St

Feb 22, 2025
pulisher
Feb 22, 2025

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 14% - Yahoo Finance

Feb 22, 2025
pulisher
Feb 21, 2025

Analysts Issue Forecasts for PACB FY2025 Earnings - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

A chromosome-scale reference assembly of Vigna radiata enables delineation of centromeres and telomeres - Nature.com

Feb 20, 2025
pulisher
Feb 20, 2025

How HiFi sequencing is making a difference for rare disease research at Children’s Mercy - Pacific Biosciences

Feb 20, 2025
pulisher
Feb 19, 2025

Traders Purchase High Volume of Pacific Biosciences of California Call Options (NASDAQ:PACB) - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Pacific Biosciences Executives Conduct Major Stock Transactions - TradingView

Feb 19, 2025
pulisher
Feb 19, 2025

Pacific Biosciences Officer Sells Over 259K Shares - TradingView

Feb 19, 2025
pulisher
Feb 19, 2025

PacBio to Present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025 - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

The Goldman Sachs Group Cuts Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.50 - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

PacBio to Participate in TD Cowen's 45th Annual Health Care Conference - Quantisnow

Feb 19, 2025
pulisher
Feb 18, 2025

Life sciences stocks fall on NIH funding concerns - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Where Pacific Biosciences Stands With Analysts - Benzinga

Feb 18, 2025
pulisher
Feb 18, 2025

Pacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by StockNews.com - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap DownTime to Sell? - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Pacific Biosciences of California (NASDAQ:PACB) Announces Quarterly Earnings Results - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

StockWatch: NIH Indirect Cost Cuts Shake Tools Stocks - Genetic Engineering & Biotechnology News

Feb 17, 2025
pulisher
Feb 17, 2025

Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Sumitomo Mitsui Trust Group Inc. Decreases Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB) - MarketBeat

Feb 17, 2025
pulisher
Feb 15, 2025

Stephens Reiterates Overweight Rating for Pacific Biosciences of California (NASDAQ:PACB) - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 15, 2025
pulisher
Feb 15, 2025

Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 15, 2025
pulisher
Feb 15, 2025

Pacific Biosciences of California (PACB) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

PacBio's Strategic Talent Move: 700K Share Package Signals Major Executive Addition - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

PacBio Grants Equity Incentive Award to New Employee - Quantisnow

Feb 14, 2025
pulisher
Feb 14, 2025

PacBio Grants Equity Incentive Award to New Employee - GlobeNewswire Inc.

Feb 14, 2025
pulisher
Feb 14, 2025

Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Ca - GuruFocus.com

Feb 14, 2025
pulisher
Feb 14, 2025

Pacific Biosciences of California (NASDAQ:PACB) Releases Earnings Results, Meets Estimates - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday - Benzinga

Feb 14, 2025
pulisher
Feb 14, 2025

PACB Stock Down Following In-Line Q4 Earnings, Revio Shipments Fall - Yahoo Finance

Feb 14, 2025
pulisher
Feb 14, 2025

UBS Adjusts Price Target on Pacific Biosciences of California to $1.50 From $2, Keeps Neutral Rating - Marketscreener.com

Feb 14, 2025

Pacific Biosciences Of California Inc Stock (PACB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pacific Biosciences Of California Inc Stock (PACB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Van Oene Mark
See Remarks
Mar 03 '25
Sale
1.41
6,486
9,126
1,497,695
Farmer Michele
See Remarks
Mar 03 '25
Sale
1.41
2,973
4,183
184,619
medical_devices ZBH
$107.57
price up icon 3.40%
medical_devices STE
$222.45
price down icon 0.89%
medical_devices PHG
$26.11
price down icon 2.03%
$68.48
price down icon 3.22%
$81.45
price down icon 2.79%
medical_devices EW
$67.95
price down icon 0.82%
Cap:     |  Volume (24h):